Home › Stocks › DRUG › All Fund Holders
DRUG — BRIGHT MINDS BIOSCIENCES INC · All Fund Holders
Funds holding (latest): 31 · Reported value held: $246.29M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Janus Henderson Group history | Q1 2026 | 1.28M | $93.52M | 0.05% | Add |
| BlackRock Inc history | Q2 2026 | 686.18K | $48.17M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 345.05K | $24.22M | 0.03% | Add |
| Point72 Asset Management history | Q2 2026 | 327.42K | $22.98M | 0.03% | New |
| Wellington Management Group history | Q2 2026 | 171.31K | $12.03M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 133.69K | $9.38M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 104.15K | $7.31M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 66.74K | $4.69M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 66.53K | $4.67M | 0.00% | New |
| Vanguard Group history | Q4 2025 | 48.58K | $3.79M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 42.47K | $2.98M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 26.97K | $1.89M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 18.60K | $1.31M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 18.03K | $1.27M | 0.00% | Add |
| D. E. Shaw & Co history | Q1 2026 | 15.45K | $1.13M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 15.54K | $1.09M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 14.90K | $1.05M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 9.61K | $674.34K | 0.00% | New |
| Franklin Resources history | Q2 2026 | 8.02K | $563.00K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 7.85K | $551.16K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 7.81K | $548.12K | 0.00% | Add |
| Arrowstreet Capital history | Q2 2026 | 7.20K | $505.37K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 6.76K | $474.62K | 0.00% | Add |
| Marshall Wace history | Q4 2025 | 4.60K | $358.98K | 0.00% | New |
| JPMorgan Chase & Co history | Q2 2026 | 4.78K | $330.54K | 0.00% | New |
| Invesco Ltd history | Q2 2026 | 4.02K | $281.92K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 3.61K | $259.68K | 0.00% | Add |
| Renaissance Technologies history | Q3 2025 | 3.50K | $212.31K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 718 | $50.47K | 0.00% | Add |
| PNC Financial Services history | Q3 2025 | 9 | $546 | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 6.17K | $433 | 0.00% | Add |